Table 1.
Invasiveness | IV infusion | Nasoenteric tube | Well accepted | Widely available | Operator dependent | Radiation exposure | Superficial lesion detection | Intra/ extraintestinal structures |
Activity of disease | |
---|---|---|---|---|---|---|---|---|---|---|
CE | + | − | + | − | + | − | + | + | − | − |
US | − | − | − | + | + | + | − | − | − | − |
PD | − | − | − | + | + | + | − | − | − | − |
CEUS | − | + | − | + | − | + | − | − | − | + |
MDCT-E | + | + | + | − | − | − | + | − | + | +/− |
MR-E | + | + | + | − | − | − | − | − | + | +/− |
TLLS | − | + | − | − | − | − | + | − | − | + |
CE: conventional enteroclysis; US: ultrasonography; PD: power Doppler; CEUS: contrast-enhanced ultrasonography; MDCT-E: multidetector CT enteroclysis; MR-E: magnetic resonance enteroclysis; TLLS: 99mTc-HMPAO-labeled leukocyte scintigraphy; IV infusion: intravascular infusion.